📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Gene augmentation trials using the Rpe65-deficient dog: contributions towards development and refinement of human clinical trials. (2012)

First Author: Petersen-Jones SM

Attributed to: Development of an AAV vector for treatment of inherited retinal dystrophy caused by RPE65 deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/978-1-4614-0631-0_24

PubMed Identifier: 22183331

Publication URI: http://europepmc.org/abstract/MED/22183331

Type: Journal Article/Review

Volume: 723

Parent Publication: Advances in experimental medicine and biology

ISSN: 0065-2598